Go to deals
Private Equity | Healthcare

Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes

Groupe Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes from the funding family.

Led by Groupe Serenis, along with Clinique Aufréry, Clinique Verdaich and Clinique des Pyrénées, the transaction has been structured as an LBO takeover, involving several financing partners, including private debt funds Zencap AM and GSO Financement, and supported by a senior debt financing provided by CIC bank. Real estate has been outsourced to Swiss Life AM.

Clinique du Chateau de Vernhes specializes in the treatment of obesity and its complications. It was founded in 1964 in Bondigoux, France, and is located in a 17th century castle on the edge of the Tarn, in the heart of a vast park, conducive to physical activity. Its medical and paramedical team offer personalized care to its patients.

Oaklins’ team in France advised the group of acquirors. The team conducted negotiations with the seller, structured financing requirements and reorganized real estate ownership.

Parties

Talk to the deal team

Xavier Auvergnat

Partner
Toulouse, France
Oaklins France

Raphaël Petit

Managing Partner
Toulouse, France
Oaklins France

Théo Cavalière

Analyst
Toulouse, France
Oaklins France

Related deals

Bolster Investment Partners has acquired a majority stake in Eternal Sun
Private Equity | Energy

Bolster Investment Partners has acquired a majority stake in Eternal Sun

Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.

Learn more
Cerbios-Pharma has been acquired by HAS Healthcare
Healthcare

Cerbios-Pharma has been acquired by HAS Healthcare

Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.

Learn more
iwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
Private Equity | Construction & Engineering Services | Energy | TMT

iwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets

iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.

Learn more